Liverpool John Moores University
Liverpool, Merseyside, L3 3AF, United Kingdom
NCT Number: NCT04679519
Examine the impact of the protein supplements leucine, HMB and BCAA on muscle recovery and inflammatory response following acute exercise.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Liverpool, Merseyside, L3 3AF, United Kingdom
Participants, both females and males, will perform an acute bout of exercise. A bout of exercise that will involve multiple drop jumps. Prior to and post exercise, functional outputs will be measured and blood will be collected to quantify the inflammatory response. The protocol will involve attending the laboratory on 6 occasions over a two week period to complete the above measures.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Perform 100 drop jumps from 40 cm height. The protocol is divided into 5 sets of 20 repetitions. Between each repetition participants get 10 seconds, and between each set 2 minutes rest. Stand on the box, drop of the box and land with feet shoulder width apart. Then immediately bend knee to approx 45 degrees and jump straight up. Throughout each jump hands are placed on hips and should not move.
Time frame: Baseline
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: Immediately after intervention.
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: 24 hours after intervention.
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: 48 hours after intervention.
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: 7 days after intervention.
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: 14 days after intervention.
Blood taken from either vein or finger will be analysed for creatine kinase, a marker of muscle damage.
Time frame: Baseline
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: Immediately after intervention.
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: 24 hours after intervention.
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: 48 hours after intervention.
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: 7 days after intervention.
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: 14 days after intervention.
Stand and sit on chair consecutively for 30 seconds with hands placed on hips.
Time frame: Baseline
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: Immediately after intervention.
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: 24 hours after intervention.
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: 48 hours after intervention.
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: 7 days after intervention.
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: 14 days after intervention.
Hands placed on hips, feet shoulder width apart. Bend knees to approx 45 degrees hold for 3 seconds and jump maximally.
Time frame: Baseline
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: Immediately after intervention.
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: 24 hours after intervention.
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: 48 hours after intervention.
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: 7 days after intervention.
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: 14 days after intervention.
Sit on chair, then flex and extend legs three times from 90 degrees position.
Time frame: Baseline
Blood from vein will be analysed for 10 different cytokines. Different cytokines include interleukins 1 beta, 2, 3, 4, 7, 8, 10, 17 and tutor necrosis factor receptor 1.
Time frame: 24 hours after intervention.
Blood from vein will be analysed for 10 different cytokines. Different cytokines include interleukins 1 beta, 2, 3, 4, 7, 8, 10, 17 and tutor necrosis factor receptor 1.
Time frame: 48 hours after intervention.
Blood from vein will be analysed for 10 different cytokines. Different cytokines include interleukins 1 beta, 2, 3, 4, 7, 8, 10, 17 and tutor necrosis factor receptor 1.
Time frame: 7 days after intervention.
Blood from vein will be analysed for 10 different cytokines. Different cytokines include interleukins 1 beta, 2, 3, 4, 7, 8, 10, 17 and tutor necrosis factor receptor 1.
Time frame: Baseline and immediately after intervention.
Blood drop from finger will be used to lactate.
Time frame: Daily for 14 days.
Record soreness on visual analogue scale from 1-10 1 = low soreness, 10 = extreme soreness.
Time frame: Daily for 14 days.
Fill out dietary intake on food diary, by weighing food.
Liverpool John Moores University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728422
Muscle Damage, Oxidative Stress
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07726979
Athletic Performance, Bone Metabolism
Surabaya, Jawa Timur - East Java, Indonesia
View Trial DetailsNCT07671443
Anxiety, Anxiety Disorders
Manouba, Tunisia
View Trial DetailsNCT07565376
Eccentric Exercise, Muscle Damage
Athens, Attica, Greece
View Trial Details